These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 38192931)

  • 1. Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine.
    Adhit KK; Wanjari A; Menon S; K S
    Cureus; 2023 Dec; 15(12):e50176. PubMed ID: 38192931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy for precision diagnostics and therapeutics.
    Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
    Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.
    Pérez-Callejo D; Romero A; Provencio M; Torrente M
    Transl Lung Cancer Res; 2016 Oct; 5(5):455-465. PubMed ID: 27826527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
    Ray SK; Mukherjee S
    Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
    Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
    Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
    Huang Z; Fu Y; Yang H; Zhou Y; Shi M; Li Q; Liu W; Liang J; Zhu L; Qin S; Hong H; Liu Y
    Mol Cancer; 2024 Feb; 23(1):36. PubMed ID: 38365716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy.
    Liu S; Wang J
    Curr Issues Mol Biol; 2022 Jun; 44(6):2695-2709. PubMed ID: 35735625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management.
    Elazezy M; Joosse SA
    Comput Struct Biotechnol J; 2018; 16():370-378. PubMed ID: 30364656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA).
    Lim M; Kim CJ; Sunkara V; Kim MH; Cho YK
    Micromachines (Basel); 2018 Feb; 9(3):. PubMed ID: 30424034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
    Zhang X; Ju S; Wang X; Cong H
    Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
    Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
    J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review).
    Ge Q; Zhang ZY; Li SN; Ma JQ; Zhao Z
    Oncol Lett; 2024 Nov; 28(5):548. PubMed ID: 39319213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.
    Calandri M; Siravegna G; Yevich SM; Stranieri G; Gazzera C; Kopetz S; Fonio P; Gupta S; Bardelli A; Veltri A; Odisio BC
    Eur Radiol; 2020 Aug; 30(8):4496-4503. PubMed ID: 32193642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
    Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
    Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.